Stockholders' Equity At-the-Market Offering (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Subsidiary, Sale of Stock [Line Items] | |||
| Number of shares authorized to be sold under equity distribution agreement (in shares) | 11,000,000 | ||
| Number of common shares issued under equity distribution agreement and outstanding as of period-end (in shares) | 2,183,178 | ||
| Accumulated proceeds from issuance of common shares under equity distribution agreement | $ 134,800 | ||
| Issuance of stock, net of offering costs | $ 6,614 | $ 450,602 | $ 372 |
| At the Market Offering [Member] | |||
| Subsidiary, Sale of Stock [Line Items] | |||
| Number of shares of stock issued during period (in shares) | 307,569 | 3,050 | 0 |
| Issuance of stock, net of offering costs | $ 6,100 | $ 100 | $ 0 |
| X | ||||||||||
- Definition The number of shares authorized to be sold under an at-the-market Equity Distribution Agreement. No definition available.
|
| X | ||||||||||
- Definition Number of shares issued and outstanding as of period-end from an at-the-market common stock offering. No definition available.
|
| X | ||||||||||
- Definition Proceeds from (value of) stock issued and outstanding as of period-end from an at-the-market common stock offering. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|